Badger-founded Constantiam Biosciences secures $2M from the NIH
- Jun. 14, 2024
Constantiam Biosciences is a biotechnology start-up company founded by three Wisconsin grads — Nicholas Schafer ’08, Daniel Goldman ’07, and Norman Ong ’07 — focused on interpreting the vast diversity of human genetic variation to improve outcomes for patients afflicted by cancer, neurodegeneration, and cardiovascular disease. The company has been awarded a $2M Small Business Innovation Research (SBIR) grant from the National Human Genome Research Institute (NHGRI) to develop technologies aimed at addressing medically inactionable variants of uncertain significance (VUS) uncovered in clinical genetic tests. Constantiam’s technologies enable classification of VUS to improve patient outcomes across a wide variety of medical conditions, unlocking the power of precision medicine.
More Alumni Notes
Natcast announced the addition of semiconductor veteran Michael Splinter ’72, MS’74 to its Board of Trustees. Natcast is the nonprofit operator of the National Semiconductor Technology Center (NSTC) established by the CHIPS and Science Act of the ...
UW mechanical engineering alumnus, Bjorn Borgen ’62, was recently inducted into the Colorado Snowsports Hall of Fame.
Natcast announced the addition of semiconductor veteran Michael Splinter ’72, MS’74 to its Board of Trustees. Natcast is the nonprofit operator of the National Semiconductor Technology Center (NSTC) established by the CHIPS and Science Act of the ...
UW mechanical engineering alumnus, Bjorn Borgen ’62, was recently inducted into the Colorado Snowsports Hall of Fame.
Natcast announced the addition of semiconductor veteran Michael Splinter ’72, MS’74 to its Board of Trustees. Natcast is the nonprofit operator of the National Semiconductor Technology Center (NSTC) established by the CHIPS and Science Act of the ...
UW mechanical engineering alumnus, Bjorn Borgen ’62, was recently inducted into the Colorado Snowsports Hall of Fame.